Refractory Hypotension In Distributive Shock clinical trials

Explore recruiting refractory hypotension in distributive shock clinical trials.

Also recruiting in Europe

Refractory Hypotension In Distributive Shock trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase III randomised, double-blind, placebo-controlled, multicentre efficacy and safety clinical trial of angiotensin II in paediatric patients of 0 to 17 years of age with refractory hypotension in distributive shock receiving fluid resuscitation and standard-of-care vasopressors

Italy, Germany, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Refractory Hypotension In Distributive Shock trials by city

Refractory Hypotension In Distributive Shock in Toronto Refractory Hypotension In Distributive Shock in Vancouver Refractory Hypotension In Distributive Shock in Montreal Refractory Hypotension In Distributive Shock in Calgary Refractory Hypotension In Distributive Shock in Edmonton Refractory Hypotension In Distributive Shock in Ottawa Refractory Hypotension In Distributive Shock in Winnipeg Refractory Hypotension In Distributive Shock in Quebec City Refractory Hypotension In Distributive Shock in Hamilton Refractory Hypotension In Distributive Shock in Kitchener Refractory Hypotension In Distributive Shock in London Refractory Hypotension In Distributive Shock in Halifax Refractory Hypotension In Distributive Shock in New York Refractory Hypotension In Distributive Shock in Los Angeles Refractory Hypotension In Distributive Shock in Chicago Refractory Hypotension In Distributive Shock in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease